Related Experiment Video
Updated: May 6, 2026

A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
Published on: June 25, 2014
Insulin downregulates the expression of the Ca2+-activated nonselective cation channel TRPM5 in pancreatic islets
Barbara Colsoul1, Griet Jacobs, Koenraad Philippaert
1Laboratory of Ion Channel Research, KU Leuven, Herestraat 49, bus 802, Leuven, 3000, Belgium.
Abstract:
We recently proposed that the transient receptor potential melastatin 5 (TRPM5) cation channel contributes to glucose-induced electrical activity of the β cell and positively influences glucose-induced insulin release and glucose homeostasis. In this study, we investigated Trpm5 expression and function in pancreatic islets from mouse models of type II diabetes. Gene expression analysis revealed a strong reduction of Trpm5 mRNA levels in pancreatic islets of db/db and ob/ob mice. The glucose-induced Ca(2+) oscillation pattern in db/db and ob/ob islets mimicked those of Trpm5 (-/-) islets. Leptin treatment of ob/ob mice not only reversed the diabetic phenotype seen in these mice but also upregulated Trpm5 expression. Leptin treatment had no additional effect on Trpm5 expression levels when plasma insulin levels were comparable to those of the vehicle-injected control group. In murine β cell line, MIN6, insulin downregulated TRPM5 expression in a dose-dependent manner, unlike glucose or leptin. In conclusion, our data show that increased plasma insulin levels downregulate TRPM5 expression in pancreatic islets from leptin-deficient mouse models of type 2 diabetes.
Insights
Transient Receptor Potential Melastatin 5 (TRPM5) channel expression is reduced in type 2 diabetes models. Increased insulin levels downregulate TRPM5, impacting glucose homeostasis and insulin release.
Area of Science:
- Endocrinology
- Molecular Biology
- Physiology
Background:
- Transient Receptor Potential Melastatin 5 (TRPM5) cation channel is crucial for glucose-induced insulin release and homeostasis.
- Dysregulation of TRPM5 may contribute to the pathophysiology of type 2 diabetes.
Purpose of the Study:
- To investigate the expression and function of Trpm5 in pancreatic islets of mouse models for type 2 diabetes.
- To explore the relationship between leptin, insulin, and Trpm5 expression in diabetes.
Main Methods:
- Gene expression analysis of Trpm5 mRNA in pancreatic islets.
- Assessment of glucose-induced Ca(2+) oscillations in islets.
- Leptin treatment in ob/ob mice and insulin treatment in MIN6 cells.
Main Results:
- Trpm5 mRNA levels were significantly reduced in db/db and ob/ob mice.
- Glucose-induced Ca(2+) oscillations in db/db and ob/ob islets resembled Trpm5 (-/-) islets.
- Leptin treatment upregulated Trpm5 in ob/ob mice, but insulin downregulated TRPM5 in MIN6 cells.
Conclusions:
- Reduced Trpm5 expression is associated with type 2 diabetes in mice.
- Elevated plasma insulin levels downregulate TRPM5 expression in pancreatic islets.
- TRPM5 plays a role in the altered islet function observed in type 2 diabetes.
More Related Videos
10:09Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Insulin: The Receptor and Signaling Pathways
Cell Specific Gene Expression
Insulin Secretory Vesicles
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology